Key result
Cisplatin-gemcitabine chemotherapy triggers multivessel acute arterial thromboembolism in a lymphoma patient.
Why the study?
Chemotherapy may further heighten the well-known risk of thromboembolic events in patients with active cancer.
Does Cisplatin-Gemcitabine based chemotherapy increase the risk of acute arterial thromboembolism in patients with Diffuse Large B-Cell Non-Hodgkin's Lymphoma?
Case Report (n=1)
Does Cisplatin-Gemcitabine based chemotherapy increase the risk of acute arterial thromboembolism in patients with Diffuse Large B-Cell Non-Hodgkin's Lymphoma?
Answers are grounded in this paper and cite their sources.
Cisplatin-based chemotherapy may increase the risk of acute arterial thromboembolic events, requiring a high index of suspicion for unusual symptoms in cancer patients.
OBJECTIVES: The increased risk of thromboembolic complications with active cancer is well known. We present this case to highlight that chemotherapy may increase the risk of thromboembolic events even further in cancer patients. METHODS: We report a case of a 64-year-old male with Diffuse Large B-Cell Non-Hodgkin's Lymphoma who presented with left-sided headache and right calf pain two weeks after starting Rituximab/Gemcitabine/Cisplatin/Dexamethasone chemotherapy. Neurological examination was normal, but there was an absent right dorsalis pedis pulse. He subsequently developed left vision loss. CT angiogram of the head and neck revealed occlusion of his left internal carotid artery and poor opacification of the left ophthalmic artery. An angiogram of the right leg further revealed acute occlusion of the popliteal artery. RESULTS: The patient underwent intra-arterial Tissue Plasminogen Activator injection to his lower limb and was started on Low Molecular Weight Heparin. His vision gradually recovered with time. His chemotherapy regimen was changed to RICE (Rituximab, Ifosfamide, Carboplatin, Etoposide). CONCLUSION: Based on literature review, there are numerous similar presentations of arterial thromboembolism in patients on Cisplatin-based chemotherapy. A high index of suspicion for such events should be maintained for patients on chemotherapy presenting with unusual symptoms.
No takes yet. Share an insight, caveat, or question.
Zafar et al. (2018) conducted a case report in Diffuse Large B-Cell Non-Hodgkin's Lymphoma (n=1). Cisplatin-Gemcitabine based chemotherapy was evaluated on Acute arterial occlusion. A 64-year-old male with Diffuse Large B-Cell Lymphoma developed acute left internal carotid artery and right popliteal artery occlusions two weeks after starting Cisplatin-Gemcitabine chemotherapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: